Janus Henderson Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.6M | Sell |
|
|||||
|
2025
Q1 | $91.7M | Sell |
|
|||||
|
2024
Q4 | $148M | Buy |
|
|||||
|
2024
Q3 | $86.4M | Buy |
|
|||||
|
2024
Q2 | $968K | Hold |
|
|||||
|
2024
Q1 | $840K | Hold |
|
|||||
|
2023
Q4 | $622K | Hold |
|
|||||
|
2023
Q3 | $607K | Sell |
|
|||||
|
2023
Q2 | $500K | Sell |
|
|||||
|
2023
Q1 | $694K | Hold |
|
|||||
|
2022
Q4 | $716K | Sell |
|
|||||
|
2022
Q3 | $1.27M | Buy |
|
|||||
|
2022
Q2 | $591K | Sell |
|
|||||
|
2022
Q1 | $2.38M | Buy |
|
|||||
|
2021
Q4 | $1.82M | Hold |
|
|||||
|
2021
Q3 | $2.22M | Sell |
|
|||||
|
2021
Q2 | $2.48M | Buy |
|
|||||
|
2021
Q1 | $2.41M | Buy |
|
|||||
|
2020
Q4 | $1.96M | Sell |
|
|||||
|
2020
Q3 | $2.02M | Buy |
|
|||||
|
2020
Q2 | $2.36M | Buy |
|
|||||
|
2020
Q1 | $1.14M | Sell |
|
|||||
|
2019
Q4 | $2.92M | Sell |
|
|||||
|
2019
Q3 | $4.58M | Sell |
|
|||||
|
2019
Q2 | $12.5M | Buy |
|
|||||
|
2019
Q1 | $3.97M | Sell |
|
|||||
|
2018
Q4 | $19.8M | Buy |
|
|||||
|
2018
Q3 | $3.05M | Buy |
|
|||||
|
2018
Q2 | $3.09M | Hold |
|
|||||
|
2018
Q1 | $2.17M | Hold |
|
|||||
|
2017
Q4 | $2.41M | Sell |
|
|||||
|
2017
Q3 | $2.23M | Sell |
|
|||||
|
2017
Q2 | $104M | Sell |
|
|||||
|
2017
Q1 | $124M | Sell |
|
|||||
|
2016
Q4 | $294M | Buy |
|
|||||
|
2016
Q3 | $361M | Buy |
|
|||||
|
2016
Q2 | $385M | Buy |
|
|||||
|
2016
Q1 | $296M | Buy |
|
|||||
|
2015
Q4 | $300M | Buy |
|
|||||
|
2015
Q3 | $127M | Buy |
|
|||||
|
2015
Q2 | $109M | Sell |
|
|||||
|
2015
Q1 | $127M | Sell |
|
|||||
|
2014
Q4 | $119M | Sell |
|
|||||
|
2014
Q3 | $113M | Buy |
|
|||||
|
2014
Q2 | $80.5M | Buy |
|
|||||
|
2014
Q1 | $74.4M | Buy |
|
|||||
|
2013
Q4 | $37.8M | Buy |
|
|||||
|
2013
Q3 | $11.5M | Buy |
|
|||||
|
2013
Q2 | $11.3M | Buy |
|